Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-26T16:07:09.531Z Has data issue: false hasContentIssue false

LPS-induced reduction of triglyceride synthesis and secretion in dairy cow mammary epithelial cells via decreased SREBP1 expression and activity

Published online by Cambridge University Press:  08 August 2018

Jianfa Wang*
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Xu Zhang
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Xianjing He
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Bin Yang
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Hai Wang
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Xufei Shan
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Chunqiu Li
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Dongbo Sun
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
Rui Wu*
Affiliation:
College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing 163319, China Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, Daqing 163319, China
*
*For correspondence; e-mail: [email protected]; [email protected]
*For correspondence; e-mail: [email protected]; [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Sterol regulatory element binding protein 1 (SREBP1) has a central regulatory effect on milk fat synthesis. Lipopolysaccharides (LPS) can induce mastitis and cause milk fat depression in cows. SREBP1 is also known to be associated with inflammatory regulation. Thus, in the current study, we hypothesized that LPS-induced milk fat depression in dairy cow mammary epithelial cells (DCMECs) operates via decreased SREBP1 expression and activity. To examine the hypothesis, DCMECs were isolated and purified from dairy cow mammary tissue and treated with LPS (10 µg/ml). LPS treatment of DCMECs suppressed lipid-metabolism-related transcription factor SREBP1 mRNA expression, nuclear translocation and protein expression, leading to reduced triglyceride content. The transcription levels of acetyl-CoA carboxylase-1 and fatty acid synthetase were significantly down-regulated in DCMECs after LPS treatment, suggesting that acetyl-CoA carboxylase-1 and fatty acid synthetase involved in de novo milk fat synthesis was regulated by SREBP1. In summary, these results suggest that LPS induces milk fat depression in dairy cow mammary epithelial cells via decreased expression of SREBP1 in a time-dependent manner.

Type
Research Article
Copyright
Copyright © Hannah Dairy Research Foundation 2018 

Many researchers have investigated the synthesis and regulation mechanism of milk fat, because milk fat is important for the nutritional quality and flavor of milk. Milk fat consists predominantly of triglyceride (TG; >95%), diglyceride (2%), phospholipids (1%), cholesterol (0·5%) and small amount of free fatty acids (FFA) (~0·1%) in all mammals (Staniewski et al. Reference Staniewski, Kielczewska, Smoczyński, Baranowska, Czerniewicz and Brandt2012). Milk fat is the major material basis for the nutritional quality in milk, which can provide nutrition and energy to human beings. Mammary epithelial cells can synthesize and secrete FA. There are two main sources of milk FA: short chain (4–8 C) and medium chain (10–14 C), and a portion of 16-C FA that arise de novo almost exclusively from DCMECs using acetic acid, β-hydroxybutyric acid and glycerol as precursor substances that are catalyzed by acetyl-CoA carboxylase-1 (ACC1) and fatty acid synthase (FAS). Remaining 16-C FA and long chain FA (>16 C) are obtained from the blood of cows and are produced by DCMECs using lipoprotein lipase (LPL), acetyl-CoA binding protein (ACBP), CD36 and other FA transport enzymes (Bionaz and Loor, Reference Bionaz and Loor2008). Lipid-metabolism-related transcription factor sterol regulatory element binding protein 1 (SREBP1) regulates the synthesis of dairy cow milk fat by regulating expression of the above-mentioned FA-synthesizing genes, SREBP1 plays an important role in milk fat uptake, transport, and de novo synthesis (Ma, 2012; Rincon et al. Reference Rincon, Islastrejo, Castillo, Bauman, German and Medrano2012).

Lipopolysaccharides (LPS) from the cell wall of Gram-negative bacteria are also referred to as a bacterial endotoxin. Bacteria will release LPS during clinical disease such as ruminal acidosis, mammary and uterine infection as well as during heat stress (Gott, Reference Gott2011). LPS is harmful to dairy cows, causing systemic and local inflammatory reactions, and leading to a serious decrease in milk fat percentage and yield, and consequent major economic losses in the dairy farming and processing industries. It is known that LPS can reduce the content of milk fat synthetic precursors in the blood. LPS also induces acute phase reactions of the liver, resulting in damage to the liver that then does not provide sufficient amounts of apolipoproteins required for VLDL assembly. Since VLDL particles are an important source of fatty acids for milk fat production, LPS-induced acute phase reactions of the liver can lead to a reduction in milk fat synthesis.

In addition, meta-analysis of ruminant mastitis differential gene expression spectra has indicated that SREBP1 may be involved in the adaptive response to mammary infection (Genini et al. Reference Genini, Badaoui, Sclep, Bishop, Waddington, Laan, Klopp, Cabau, Seyfert, Petzl, Jensen, Glass, Greeff, Smith, Smits, Olsaker, Boman, Pisoni, Moroni, Castiglioni, Cremonesi, Corvo, Foulon, Foucras, Rupp and Giuffra2011). SREBP1 also has a role in inflammatory regulation, and has been attracting increased research attention (Spann et al. Reference Spann, Garmire, Mcdonald, Myers, Milne, Shibata, Reichart, Fox, Shaked, Heudobler, Raetz, Wang, Kelly, Sullards, Murphy, Merrill, Brown, Dennis, Li, Ley, Tsimikas, Fahy, Subramaniam, Quehenberger, Russell and Glass2012; Wei and Espenshade, Reference Wei and Espenshade2012; Oishi et al. Reference Oishi, Spann, Link, Muse, Strid, Edillor, Kolar, Matsuzaka, Hayakawa, Tao, Kaikkonen, Carlin, Lam, Manabe, Shimano, Saghatelian and Glass2017). It is unclear whether LPS can regulate the expression and activity of SREBP1, and hence influence the synthesis of milk fat in DCMECs. Thus, in the current study, we hypothesized that LPS-induced milk fat depression in DCMECs operates via decreased SREBP1 expression and activity. These results will provide a scientific basis to study further the regulatory mechanism of milk fat synthesis and improve the nutritional quality of cow's milk.

Materials and methods

Isolation of DCMECs and LPS treatment

Primary DCMECs were cultured and purified as described previously (Xu et al. Reference Xu, Wang, He, Wang, Yang, Sun, Sun, He, Zhang and Wu2017). Experiments were performed using the 5th passage DCMECs. Forty-eight hours before treatment, insulin and hydrocortisone concentrations were reduced to 0%, and the concentration of other components was unchanged. LPS (Escherichia coli 055:B5; 10 µg/ml; Sigma) was added to the new medium. DCMECs were treated with LPS and collected for subsequent analysis. Experiments were repeated three times.

Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR)

Total RNA from DCMECs was extracted with TRIzol reagent (Sigma). The concentration and mass of RNA were measured at 260/280 nm using an ultraviolet spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). RNA with OD260/280 1·8–2·0 was reverse-transcribed to cDNA using PrimeScript RT Reagent Kit with gDNA Eraser (TaKaRa Biotechnology, Tokyo, Japan). qRT-PCR primers were designed using Primer 5.0 software (Applied Biosystems, Foster City, CA, USA; sequences are given in online Supplementary Table S1). qRT-PCR was performed using the Bio-Rad CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA), and SYBR Premix Ex Taq (TaKaRa Biotechnology). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a reference gene (Wu et al. Reference Wu, Liu, Yang, Wang and Zhu2015). The relative expression level of genes was calculated by normalizing to GAPDH using the 2−ΔΔCt method (Huang et al. Reference Huang, Gao, Li, Lu, Liu, Luo, Wang, Qiao and Jin2012; Li et al. Reference Li, Zhao, Wei, Liang, Zhang, Wang, Li and Gao2014).

Western blotting

Western blotting for SREBP1 in DCMECs was performed as described previously (Liu et al. Reference Liu, Zhang, Lin, Bian, Gao, Qu and Li2016; Song et al. Reference Song, Li, Gu, Fu, Peng, Zhao, Zhang, Li, Wang, Li and Liu2016). Primary antibodies: mouse anti-SREBP1 monoclonal antibody (ab3259; 1 : 1000 dilution; Abcam); rabbit anti-β-actin antibody (bs-0061R; 1 : 2000 dilution; Bioss, Woburn, MA, USA). Secondary antibodies: horseradish peroxidase (HRP)-labeled goat anti-mouse IgG (H + L) (ab6789; 1 : 5000 dilution; Abcam); HRP-labeled goat anti-rabbit IgG (H + L) (ab205718; 1 : 5000 dilution; Abcam). The ECL signal was detected using a gel imaging system, and OD values of western blotting images were analyzed using Image-Pro Plus 6·0 software (IPP; Media Cybernetics, Bethesda, MD, USA).

Nuclear translocation assay of SREBP1

Nuclear translocation for SREBP1 in DCMECs was performed as described previously (Huang et al. Reference Huang, Zhao, Luo, Zhang, Si, Sun, Zhang, Li and Gao2013). Primary antibodies: mouse anti-SREBP1 monoclonal antibody (ab3259; 1 : 1000 dilution; Abcam). Secondary antibodies: Alexa Fluor 488-labeled goat anti-mouse IgG (ab150117; 1 : 500 dilution; Abcam). The coverslips were photographed using laser confocal microscopy (Leica).

BODIPY493/503 staining of lipid droplets

Staining for lipid droplets in DCMECs was performed as described previously (Lee et al. Reference Lee, Mendez, Heng, Yang and Zhang2012).

Determination of TG content

The total protein concentration of cells was determined by the Enhanced BCA Protein Assay Kit (Pierce, Rockford, IL, USA). TG concentration of the DCMECs was quantification using the Tissue Triglyceride Assay Kit (Applygen Technologies, Beijing, China) at 550 nm. The TG concentration of DCMECs was corrected to concentration per mg protein (He et al. Reference He, He, Liao, Niu, Wang, Zhao, Wang, Tian, Li and Sun2012; Shi et al. Reference Shi, Li, Deng, Peng, Zhao, Li, Wang, Li and Liu2016).

Statistical analysis

Each sample was assessed in triplicate and the experimental data were expressed as the mean ± sd. The data were analyzed by one-way analysis of variance using SPSS version 19·0 software (SPSS, IBM, Armonk, NY, USA). The differences were considered significant at P < 0·05 and highly significant at P < 0·01.

Results

LPS decreases transcription, translation and nuclear translocation of SREBP1

The mRNA expression level of SREBP1 was reduced in DCMECs treated with LPS for 3 h, and gradually decreased further with LPS treatment time (P < 0·01 or P < 0·05). Transcription of SREBP1 was lowest at 12 h after LPS treatment, and then began to increase gradually (P < 0·01). However, the trend for increased SREBP1 transcription after LPS treatment for 24 and 48 h was not obvious, and the difference was not significant (P > 0·05) (Fig. 1a).

Fig. 1. Transcription, translation and nuclear translocation of SREBP1 in DCMECs. (a) Transcription levels of SREBP1. (b) Western blotting of SREBP1. (c) The grayscale analysis of SREBP1. (D) Nuclear translocation assay of SREBP1. Note: The data with different capital letters between two groups showed very significant differences (P < 0·01); data with different lower-case letters between two groups showed significant differences (P < 0·05); data with the same letters between two groups showed no significant differences (P > 0·05).

Western blotting revealed that protein expression of SREBP1 was down-regulated in DCMECs treated with LPS for 1 h, and gradually decreased further with LPS treatment time (P < 0·01). Expression of SREBP1 protein was lowest at 24 h after LPS treatment, and then began to increase gradually (P < 0·05) (Fig. 1b, c).

Immunofluorescence revealed that after treatment with LPS for 1 h, the intracellular trafficking of mature SREBP1 to the nucleus was inhibited. The levels of intracellular trafficking of mature SREBP1 to the nucleus were inhibited least at 24 h after LPS treatment, and then began to increase gradually (Fig. 1d). These results suggest that treatment with LPS decreases expression and activity of SREBP1 in DCMECs in a time-dependent manner.

LPS decreases transcription levels of FAS and ACC1

Transcription of FAS was down-regulated in DCMECs treated with LPS for 3 h, and gradually decreased further with LPS treatment time (P < 0·01). Transcription of FAS was lowest at 24 h after LPS treatment, and then began to increase gradually (P < 0·01) (Fig. 2a). The transcriptional changes of ACC1 are consistent with those of FAS (Fig. 2b).

Fig. 2. Transcription levels of FAS and ACC1 in DCMECs. (a) Transcription levels of FAS. (b) Transcription levels of ACC1. Note: The data with different capital letters between two groups showed very significant differences (P < 0·01); data with different lower-case letters between two groups showed significant differences (P < 0·05); data with the same letters between two groups showed no significant differences (P > 0·05).

LPS decreases milk fat synthesis

The content of TG was decreased in DCMECs treated with LPS for 3 h, and gradually decreased further with LPS treatment time (P < 0·01 or P < 0·05). The content of lipid droplets was lowest at 12 h after LPS treatment, and then began to increase gradually (P < 0·05) (Fig. 3). However, the trend for increased milk fat synthesis after LPS treatment for 24 and 48 h was not obvious and the difference was not significant (P > 0·05). The results of the lipid droplets BODIPY493/503 staining was consistent with the results of the determination of TG content (data are given in online Supplementary Fig. S1). These results suggest treatment with LPS can decrease milk fat synthesis in DCMECs in a time-dependent manner.

Fig. 3. Concentration of TG in DCMECs. Note: The data with different capital letters between two groups showed very significant differences (P < 0·01); data with different lower-case letters between two groups showed significant differences (P < 0·05); data with the same letters between two groups showed no significant differences (P > 0·05).

Discussion

SREBP1 belongs to the basic helix–loop–helix–leucine zipper family of transcription factors, and is essential for the regulation of FA and cholesterol biosynthetic gene expression (Jeon and Osborne, Reference Jeon and Osborne2012). Genome-wide association scans and functional genomics analyses have established that SREBP1 is a key regulator of milk fat synthesis and secretion (Ogorevc et al. Reference Ogorevc, Kunej, Razpet and Dovc2009). It can regulate the synthesis of fat in the body by controlling the expression of the relevant lipid-synthesizing-related enzymes involved in the synthesis and uptake of cholesterol, FA, TG and phospholipids. Normally, SREBP1 in the endoplasmic reticulum is an inactive precursor. When cells are stimulated by liver X receptor, specificity protein 1 and oxysterols, SREBP1 is activated. Following activation, the amino terminal fragments of SREBP1 translocate to the nucleus and initiate transcription of target genes in combination with the SREs within the promoters of target genes (Zhang et al. Reference Zhang, Zhang, Hui, Lei, Du, Gao, Zhang, Liu, Li and Li2015). Numerous cell culture experiments and genetically modified mouse models have shown that the major target genes of SREBP1 are some of the rate-limiting enzymes in the FA and cholesterol biosynthesis pathways. After treatment of DCMECs with SREBP1 siRNA, ACC1 and FAS content decreased by 40–65% (Ma & Corl, Reference Ma and Corl2012). It has also been found that the mRNA expression levels of SREBP1 and milk fat synthesis enzymes in dairy cows are up-regulated in lactation, indicating that SREBP1 has a central regulatory effect on milk fat synthesis (Farke et al. Reference Farke, Meyer, Bruckmaier and Albrecht2008).

Milk fat synthesis involves the de novo synthesis of FA as well as the incorporation of de novo and preformed FA into TG. The TG accumulates to form lipid droplets, primarily in the mammary gland tissues of mammals. The activation of these metabolic pathways requires the coordinated regulation of a network of genes encoding lipogenic enzymes, such as the lipid-metabolism-related transcription factor SREBP1, as well as the de novo FA synthesis genes FAS and ACC1. FAS and ACC1 are the key enzymes for de novo synthesis of milk fat in DCMECs, and the gene promoter region of both has the binding site of SREBP1. Acetyl-CoA synthetase converts acetate into acetyl-CoA and begins de novo synthesis of milk fat. ACC1 catalyzes the conversion of acetyl-CoA to malonyl-CoA, a step that is the rate-limiting step in milk fat synthesis. FAS utilizes acetyl-CoA as a substrate to catalyze a series of carbon chain extension reactions to add the two carbon units from malonyl-CoA to the gradually elongated fatty acyl chain. SREBP1 translocates to the nucleus where it activates lipogenic genes by binding to the SREBP1 response element of the ACC1 and FAS genes (Kim et al. Reference Kim, Shin, Seo, Byun, Yoon, Lee, Hyun, Chung and Yoon2010). The mRNA transcription levels of ACC1 and FAS, as well as TG secretion and lipid droplets formation represent the DCMECs’ capacity for milk fat synthesis. In this study, we found that SREBP1 affected the mRNA expression levels of the FAS and ACC1 genes in accordance with changes in TG content and lipid droplets accumulation, further confirming that SREBP1 acts on its target genes to regulate milk fat synthesis in DCMECs.

LPS is an important pathogen-associated molecular pattern that reduces the concentration of milk fat synthetic precursors in the blood of dairy cows, and can also be identified by pattern recognition receptors (e.g. Toll-like receptor 4) on the surface of mammary epithelial cells, resulting in up-regulated DNA binding activity of nuclear factor (NF)-κB and increased expression of inflammatory cytokines including TNFα, IL-1β, IL-6 and IL-8. This creates a highly inflammatory cytokine state in the mammary tissue and even in the body as a whole (Miao et al. Reference Miao, Fa, Gu, Zhu and Zou2012). The binding site of NF-κB has been found in the promoter region of SREBP1 (Zhang et al. Reference Zhang, Shin and Osborne2005). These results suggest that the inflammatory signaling pathway has the potential to regulate lipid metabolism.

In this study, LPS decreased the concentration of TG and the formation of lipid droplets in DCMECs, and decreased the transcriptional and nuclear translocation of lipogenic transcription factor SREBP1 in DCMECs. At the same time, LPS decreased the expression of milk fat de novo synthesis-related enzyme genes in DCMECs. Moreover, these results suggest that LPS affects the synthesis of dairy cow milk fat by down-regulating expression of SREBP1 and milk fat de novo synthesis of related enzyme genes. Nevertheless, expression of milk-fat-synthesis-related genes and proteins and TG is not always decreased after DCMECs are treated with LPS, but with the prolongation of treatment, there is a tendency for increased expression of milk-fat-synthesis-related genes and proteins and TG. This may be due to the fact that LPS is identified by the pattern recognition receptor on the surface of mammary epithelial cells to up-regulate the DNA binding activity of NF-κB, increase the transcription of SREBP1, and enable SREBP1 to participate in inflammatory regulation. However, this still needs validation. This may explain why cow mastitis can further aggravate the depression of milk fat.

In conclusion, our study suggests that LPS induces milk fat depression in DCMECs via decreased SREBP1 expression and activity in a time-dependent manner.

Conflict of interests

All the authors in this article claim no conflicts of interest.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/S0022029918000547.

The present study was jointly financially supported by the National Natural Science Foundation of China (31472249, 31402157, and 31772698), the Natural Science Foundation of Heilongjiang province (QC2016045), the Doctoral Fund of Ministry of Education of China (2016M601465), the University Nursing Program for Young Scholars with Creative Talents in Heilongjiang Province (UNPYSCT-2015087), and the Startup Foundation for the Doctors in Heilongjiang Bayi Agricultural University (XYB2014-12).

References

Bionaz, M & Loor, JJ 2008 Gene networks driving bovine milk fat synthesis during the lactation cycle. BMC Genomics 9 366Google Scholar
Farke, C, Meyer, HH, Bruckmaier, RM & Albrecht, C 2008 Differential expression of ABC transporters and their regulatory genes during lactation and dry period in bovine mammary tissue. Journal of Dairy Research 75 406414Google Scholar
Genini, S, Badaoui, B, Sclep, G, Bishop, SC, Waddington, D, Laan, MH, Klopp, C, Cabau, C, Seyfert, HM, Petzl, W, Jensen, K, Glass, EJ, Greeff, AD, Smith, HE, Smits, MA, Olsaker, I, Boman, GM, Pisoni, G, Moroni, P, Castiglioni, B, Cremonesi, P, Corvo, MD, Foulon, E, Foucras, G, Rupp, R & Giuffra, E 2011 Strengthening insights into host responses to mastitis infection in ruminants by combining heterogeneous microarray data sources. BMC Genomics 12 315316Google Scholar
Gott, PN 2011 Endotoxin Tolerance in Lactating Dairy Cows. Columbus, USA: The Ohio State UniversityGoogle Scholar
He, YH, He, Y, Liao, XL, Niu, YC, Wang, G, Zhao, C, Wang, L, Tian, MJ, Li, Y & Sun, CH 2012 The calcium-sensing receptor promotes adipocyte differentiation and adipogenesis through PPARγ pathway. Molecular and Cellular Biochemistry 361 321328Google Scholar
Huang, JG, Gao, XJ, Li, QZ, Lu, LM, Liu, R, Luo, CC, Wang, JL, Qiao, B & Jin, X 2012 Proteomic analysis of the nuclear phosphorylated proteins in dairy cowmammary epithelial cells treated with estrogen. In Vitro Cellular and Developmental Biology-Animal 48 449457Google Scholar
Huang, YL, Zhao, F, Luo, CC, Zhang, X, Si, Y, Sun, Z, Zhang, L, Li, QZ & Gao, XJ 2013 SOCS3-mediated blockade reveals major contribution of JAK2/STAT5 signaling pathway to lactation and proliferation of dairy cow mammary epithelial cells in vitro. Molecules 18 1298713002Google Scholar
Jeon, TI & Osborne, TF 2012 SREBPs: metabolic integrators in physiology and metabolism. Trends in Endocrinology and Metabolism Tem 23 6572Google Scholar
Kim, YM, Shin, HT, Seo, YH, Byun, HO, Yoon, SH, Lee, IK, Hyun, DH, Chung, HY & Yoon, G 2010 Sterol regulatory element-binding protein (SREBP)-1-mediated lipogenesis is involved in cell senescence. Journal of Biological Chemistry 285 2906929077Google Scholar
Lee, JS, Mendez, R, Heng, HH, Yang, ZQ & Zhang, K 2012 Pharmacological ER stress promotes hepatic lipogenesis and lipid droplet formation. American Journal of Translational Research 4 102113Google Scholar
Li, N, Zhao, F, Wei, C, Liang, M, Zhang, N, Wang, C, Li, QZ & Gao, XJ 2014 Function of SREBP1 in the milk fat synthesis of dairy cow mammary epithelial cells. International Journal of Molecular Sciences 15 1699817013Google Scholar
Liu, L, Zhang, LI, Lin, YE, Bian, Y, Gao, X, Qu, B & Li, Q 2016 14-3-3γ regulates cell viability and milk fat synthesis in lipopolysaccharide-induced dairy cow mammary epithelial cells. Experimental and Therapeutic Medicine 11 12791287Google Scholar
Ma, L & Corl, BA 2012 Transcriptional regulation of lipid synthesis in bovine mammary epithelial cells by sterol regulatory element binding protein-1. Journal of Dairy Science 95 37433755Google Scholar
Miao, J, Fa, Y, Gu, B, Zhu, W & Zou, S 2012 Taurine attenuates lipopolysaccharide-induced disfunction in mouse mammary epithelial cells. Cytokine 59 3540Google Scholar
Ogorevc, J, Kunej, T, Razpet, A & Dovc, P 2009 Database of cattle candidate genes and genetic markers for milk production and mastitis. Animal Genetics 40 832851Google Scholar
Oishi, Y, Spann, NJ, Link, VM, Muse, ED, Strid, T, Edillor, C, Kolar, MJ, Matsuzaka, T, Hayakawa, S, Tao, J, Kaikkonen, MU, Carlin, AF, Lam, MT, Manabe, I, Shimano, H, Saghatelian, A & Glass, CK 2017 SREBP1 contributes to resolution of pro-inflammatory TLR4 signaling by reprogramming fatty acid metabolism. Cell Metabolism 25 412427Google Scholar
Rincon, G, Islastrejo, A, Castillo, AR, Bauman, DE, German, BJ & Medrano, JF 2012 Polymorphisms in genes in the SREBP1 signalling pathway and SCD are associated with milk fatty acid composition in Holstein cattle. Journal of Dairy Research 79 6675Google Scholar
Shi, X, Li, D, Deng, Q, Peng, Z, Zhao, C, Li, X, Wang, Z, Li, X & Liu, G 2016 Acetoacetic acid induces oxidative stress to inhibit the assembly of very low density lipoprotein in bovine hepatocytes. Journal of Dairy Research 83 442446Google Scholar
Song, Y, Li, N, Gu, J, Fu, S, Peng, Z, Zhao, C, Zhang, Y, Li, X, Wang, Z, Li, X & Liu, G 2016 β-Hydroxybutyrate induces bovine hepatocyte apoptosis via an ROS-p38 signaling pathway. Journal of Dairy Science 99 91849198Google Scholar
Spann, NJ, Garmire, LX, Mcdonald, JG, Myers, DS, Milne, SB, Shibata, N, Reichart, D, Fox, JN, Shaked, I, Heudobler, D, Raetz, CR, Wang, EW, Kelly, SL, Sullards, MC, Murphy, RC, Merrill, AH Jr, Brown, HA, Dennis, EA, Li, AC, Ley, K, Tsimikas, S, Fahy, E, Subramaniam, S, Quehenberger, O, Russell, DW & Glass, CK 2012 Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 151 138152Google Scholar
Staniewski, B, Kielczewska, K, Smoczyński, M, Baranowska, M, Czerniewicz, M & Brandt, W 2012 Effect of high pressures on the composition of milk fat triacylglycerols. Milchwissenschaft-milk Science International 67 1821Google Scholar
Wei, S & Espenshade, PJ 2012 Expanding roles for SREBP in metabolism. Cell Metabolism 16 414419Google Scholar
Wu, Q, Liu, MC, Yang, J, Wang, JF & Zhu, YH 2015 Lactobacillus rhamnosus GR-1 ameliorates Escherichia coli-induced inflammation and cell damage via attenuation of ASC-independent NLRP3 inflammasome activation. Applied and Environmental Microbiology 82 11731182Google Scholar
Xu, DD, Wang, G, He, XJ, Wang, JF, Yang, B, Sun, ZP, Sun, DB, He, QY, Zhang, X & Wu, R 2017 17β-Estradiol and progesterone decrease MDP induced NOD2 expression in bovine mammary epithelial cells. Veterinary Immunology Immunopathology 188 5964Google Scholar
Zhang, C, Shin, DJ & Osborne, TF 2005 A simple promoter containing two Sp1 sites controls the expression of sterol-regulatory-element-binding protein 1a (SREBP-1a). Biochemical Journal 386 161168Google Scholar
Zhang, M, Zhang, S, Hui, Q, Lei, L, Du, X, Gao, W, Zhang, R, Liu, G, Li, X & Li, X 2015 β-Hydroxybutyrate facilitates fatty acids synthesis mediated by sterol regulatory element-binding protein1 in bovine mammary epithelial cells. Cellular Physiology and Biochemistry 37 21152124Google Scholar
Figure 0

Fig. 1. Transcription, translation and nuclear translocation of SREBP1 in DCMECs. (a) Transcription levels of SREBP1. (b) Western blotting of SREBP1. (c) The grayscale analysis of SREBP1. (D) Nuclear translocation assay of SREBP1. Note: The data with different capital letters between two groups showed very significant differences (P < 0·01); data with different lower-case letters between two groups showed significant differences (P < 0·05); data with the same letters between two groups showed no significant differences (P > 0·05).

Figure 1

Fig. 2. Transcription levels of FAS and ACC1 in DCMECs. (a) Transcription levels of FAS. (b) Transcription levels of ACC1. Note: The data with different capital letters between two groups showed very significant differences (P < 0·01); data with different lower-case letters between two groups showed significant differences (P < 0·05); data with the same letters between two groups showed no significant differences (P > 0·05).

Figure 2

Fig. 3. Concentration of TG in DCMECs. Note: The data with different capital letters between two groups showed very significant differences (P < 0·01); data with different lower-case letters between two groups showed significant differences (P < 0·05); data with the same letters between two groups showed no significant differences (P > 0·05).

Supplementary material: PDF

Wang et al. supplementary material

Wang et al. supplementary material 1

Download Wang et al. supplementary material(PDF)
PDF 294.6 KB